Portfolio Company Job Board

Find a job at one of our innovative portfolio companies
Sands Capital
Sands Capital
77
companies
3,295
Jobs
Dice Therapeutics
Dice Therapeutics
dicetherapeutics.com

Locations

San Francisco, CA, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Other

founded in

2013

DICE Therapeutics is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. DICE is initially focused on developing oral therapeutics against well-validated targets in immunology, with the goal of achieving comparable potency to their systemic biologic counterparts, which have demonstrated the greatest therapeutic benefit to date in these disease areas. The Company’s DELSCAPE platform is designed to discover selective oral small molecules with the potential to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. DICE’s lead therapeutic candidate, S011806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17), which is a validated drug target implicated in a variety of immunology indications. DICE is also developing oral therapeutic candidates targeting α4ß7 integrin and αVß1/αVß6 integrin for the treatment of inflammatory bowel disease and idiopathic pulmonary fibrosis, respectively.

Something looks off?
Open jobs at Dice Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.